|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | CHS828 | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||||||
| 化学式 | C19H22ClN5O |
||||||||||||||
| 分子量 | 371.86 | CAS No. | 200484-11-3 | ||||||||||||
| Solubility (25°C)* | 体外 | DMSO | 74 mg/mL (198.99 mM) | ||||||||||||
| Water | Insoluble | ||||||||||||||
| Ethanol | Insoluble | ||||||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||||||
| 製品説明 | GMX1778は、ニコチンアミドホスホリボシルトランスフェラーゼ(NAMPT)の強力かつ特異的な阻害剤であり、IC50およびKdはそれぞれ25 nM未満および120 nMです。GMX1778は、アポトーシスを特徴とするプログラム細胞死を誘発します。フェーズ1。 |
|---|---|
| in vitro | GMX1778 induces NAD+ depletion through inhibition of NAD+ biosynthesis, followed by ATP depletion and ultimately resulted in cell death. This compound induces programmed cell death with apoptotic features. It suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity (IC50=8 nM). |
| in vivo | GMX1778 (250 mg/kg, p.o.) shows marked antitumoural activity against three different human neuroendocrine tumours, midgut carcinoid (GOT1), pancreatic carcinoid (BON), and medullary thyroid carcinoma (GOT2), transplanted in nude mice. |
| キナーゼアッセイ | In vitro coupled-enzyme NAMPT assay | |
|---|---|---|
| Recombinant NAMPT activity is assessed using a coupled-enzyme assay based on the quantitation of NAD+. Reactions are performed at room temperature for 180 min using mixtures consisting of 50 mM HEPES (pH 7.4), 50 mM KCl, 5 mM MgCl2, 0.5 mM β-mercaptoethanol, 0.005% bovine serum albumin, 1% DMSO, 2.0 U/ml lactate dehydrogenase, 4 mM sodium L-lactate, 0.4 U/ml diaphorase, 6 μΜ resazurin sodium salt, 0.4 mM PRPP, 3.0 nM NMNAT1, 125 μM ATP, 50 μM NM, and 2 to 5 μM recombinant NAMPT. Fluorescence s measured with a Tecan Safire plate reader (excitation wavelength, 560 nm; emission wavelength, 590 nm). Ki values are calculated using Graphpad Prism 4.0 software and the Cheng-Prusoff equation. | ||
| 細胞アッセイ | 細胞株 | HeLa cells |
| 濃度 | ~100 nM | |
| 反応時間 | 72 h | |
| 実験の流れ | Serial dilutions of GMX1778 in DMSO are performed to achieve a final concentration of 0.2% DMSO. Relative ATP levels after 72 h are determined using a ViaLight HS high-sensitivity cytotoxicity and cell proliferation BioAssay kit per the manufacturer's instructions. For this compound cytotoxicity rescue experiments, cells are treated with NA (10 μM) simultaneously with this chemical. Sigmoidal dose-response curves are generated by nonlinear regression analysis of variable slope using GraphPad Prism version 4.00 (GraphPad Software) to calculate 50% inhibitory (IC50) values. |
|
| 動物実験 | 動物モデル | Nude mice bearing midgut carcinoid (GOT1), pancreatic carcinoid (BON) and medullary thyroid cancer (GOT2) tumors |
| 投薬量 | ~250 mg/kg | |
| 投与方法 | p.o. | |
|

Data from [Data independently produced by , , Signal Transduction and Targeted Therapy. 2017, volume 2, Article number: 17017.]
| A skin organoid-based infection platform identifies an inhibitor specific for HFMD [ Nat Commun, 2025, 16(1):2513] | PubMed: 40082449 |
| Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles [ bioRxiv, 2025, 2025.04.25.650475] | PubMed: 40654745 |
| NAD+ regulates nucleotide metabolism and genomic DNA replication [ Nat Cell Biol, 2023, 10.1038/s41556-023-01280-z] | PubMed: 37957325 |
| Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options [ Cancers (Basel), 2023, 15(5)1415] | PubMed: 36900207 |
| Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer [ Cancer Res Commun, 2023, 10.1158/2767-9764.CRC-22-0521] | PubMed: 37707363 |
| Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer [ Cancer Res Commun, 2023, 3(10):2003-2013] | PubMed: 37707363 |
| NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer. [ Cancer Res, 2020, 80(4):890-900] | PubMed: 31857293 |
| Overexpression of the histidine triad nucleotide-binding protein 2 protects cardiac function in the adult mice after acute myocardial infarction. [ Acta Physiol (Oxf), 2020, 10.1111/apha.13439] | PubMed: 31900976 |
| Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice. [ Signal Transduct Target Ther, 2017, 2:17017] | PubMed: 29263919 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。